Constant Therapeutics

Manufacturing · 1-10 Employees

View Company Info for Free

Overview

Phone Number

(617) 245-0289

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Constant Therapeutics

Constant Therapeutics LLC is a private biopharmaceutical company focused on developing peptide and small molecule drugs, particularly Mas receptor agonists for treating COVID-19, CNS disorders, and rare diseases. The company targets significant unmet medical needs, including Duchenne Muscular Dystrophy, Epidermolysis Bullosa, and Ischemic Stroke. Its lead drug candidate, TXA127, is currently in clinical trials for various applications. Constant Therapeutics aims to leverage the Alternative Renin Angiotensin System to create innovative therapies for a wide range of health conditions.Explore more
Constant Therapeutics's Social MediaPopular SearchesConstant Therapeutics LLCTarix Orphan LLCTarix OrphanConstant TherapeuticsTarix Oncology LLCSIC Code 28,283NAICS Code 32,325Show more

Is Constant Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Constant Therapeutics

Compare insights from companies similar to Constant Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Constant Therapeutics

<$5M
1-10
Private
-
2013
N/A
$6.8M
11-50
Private
<$5M
1970
$6.7M
11-50
Private
<$5M
2009
<$5M
11-50
Private
<$5M
2008
Paul Gotfredson, Chief Financial Officer at Neuropore Therapies
Paul GotfredsonChief Financial Officer
<$5M
11-50
Private
-
2017
KB
Kelly BryantVice President, Finance
<$5M
11-50
Private
-
-
PS
Pam SchwartzkopfClinical Research Coordinator
<$5M
1-10
Private
-
2017
BS
Becky SchweighardtChief Scientific Officer and Chief Operating Officer
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Constant Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Constant Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Constant Therapeutics.

Constant Therapeutics Tech Stack

A closer look at the technologies used by Constant Therapeutics

Constant Therapeutics News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Constant Therapeutics

What is Constant Therapeutics's official website?
Constant Therapeutics's official website is www.constanttherapeutics.com
What is Constant Therapeutics's Revenue?
Constant Therapeutics's revenue is <$5 Million
What is Constant Therapeutics's SIC code?
Constant Therapeutics's SIC: 28,283
What is Constant Therapeutics's NAICS code?
Constant Therapeutics's NAICS: 32,325
How many employees does Constant Therapeutics have?
Constant Therapeutics has 1-10 employees
What industry does Constant Therapeutics belong to?
Constant Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Constant Therapeutics competition?
Constant Therapeutics top competitors include: Columbus Instruments International, Rare Disease Research, The Lung Research Center, Grace Science
What technology does Constant Therapeutics use?
Some of the popular technologies that Constant Therapeutics uses are: Squarespace Online Stores, Adobe Typekit, Microsoft 365, Google Workspace
How do I contact Constant Therapeutics?
Constant Therapeutics contact info: Phone number: (617) 245-0289 Website: www.constanttherapeutics.com
What does Constant Therapeutics do?

Constant Therapeutics LLC is a private biopharmaceutical company focused on developing peptide and small molecule drugs, particularly Mas receptor agonists for treating COVID-19, CNS disorders, and rare diseases. The company targets significant unmet medical needs, including Duchenne Muscular Dystrophy, Epidermolysis Bullosa, and Ischemic Stroke. I... ts lead drug candidate, TXA127, is currently in clinical trials for various applications. Constant Therapeutics aims to leverage the Alternative Renin Angiotensin System to create innovative therapies for a wide range of health conditions.Read More

What are Constant Therapeutics social media links?
Constant Therapeutics Linkedin page
Is Constant Therapeutics a public company?
Constant Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Constant Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.